Floatz logo

SUFENTANYL

Analgesics

Rigshospitalet, DenmarkSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Analgesics cohort.

Asset / SponsorPhaseRating
S-Ketamine
Rigshospitalet, Denmark
Phase 4BB
NEPENTHE
Rigshospitalet, Denmark
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Evangelismos Hospital
Phase 4BB
Zofran
Rigshospitalet, Denmark
Phase 4BB
HYDROMORPHON
Phase 3B

View all 15 →

Same molecule, other indications

SUFENTANYL is also rated in:

chronic pain syndromeDormant
BB
Indicative ·
69 / 100
View asset →
Post Operative PainDormant
BB
Indicative ·
68 / 100
View asset →
chronic pain syndromeDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →